Full Text
Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1- A Canadian Cost-Utility Analysis

Abstract

Authors

E Arthurs T Ward O Darlington D Sugrue AA Martin SE Cartier A Lee DL Becker YS Punekar P McEwan

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×